INTEGER HOLDINGS CORPORATION (ITGR) Free cash flow
- Free cash flow · 12 months (USD): Value $111.98M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-07-03..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-07-03..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-07-03..
- Free cash flow margin · 12 months: Value 6.07%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-07-03..
Free cash flow
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $111.98M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-07-03. $205.44M − $93.46M ≈ $111.98M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 6.07% | (Operating cash flow − capital spending) / revenue. Period ending 2026-07-03. $111.98M ÷ $1.84B × 100 ≈ 6.07% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $205.44M | Cash generated by operating activities. Period ending 2026-07-03. |
| Operating cash flow / net income · 12 months | 1.60× | Operating cash flow / net income. Period ending 2026-07-03. $205.44M ÷ $128.40M ≈ 1.60× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 205.44M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 93.46M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 111.98M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 1.84B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 128.40M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-03 | $111.98M | (m) | $205.44M | $93.46M | (m) | $1.84B | (m) | $128.40M | (m) | (m) | 6.07% | 1.60× |
| 2026-04-03 | $99.80M | (m) | $189.57M | $89.77M | (m) | $1.86B | (m) | $141.80M | (m) | (m) | 5.38% | 1.34× |
| 2025-12-31 | $105.12M | (m) | $196.15M | $91.03M | (m) | $1.85B | (m) | $102.81M | (m) | (m) | 5.67% | 1.91× |
| 2025-09-26 | $121.32M | (m) | $203.96M | $82.64M | (m) | $1.83B | (m) | $86.90M | (m) | (m) | 6.63% | 2.35× |
| 2025-06-27 | $120.55M | (m) | $209.87M | $89.32M | (m) | $1.79B | (m) | $82.66M | (m) | (m) | 6.72% | 2.54× |
| 2025-03-28 | $111.74M | (m) | $213.24M | $101.50M | (m) | $1.75B | (m) | $76.90M | (m) | (m) | 6.40% | 2.77× |
| 2024-12-31 | $99.85M | (m) | $205.21M | $105.36M | (m) | $1.72B | (m) | $119.90M | (m) | (m) | 5.82% | 1.71× |
| 2024-09-27 | $74.24M | (m) | $197.56M | $123.32M | (m) | $1.71B | (m) | $113.55M | (m) | (m) | 4.33% | 1.74× |
| 2024-06-28 | $65.58M | (m) | $188.35M | $122.77M | (m) | $1.67B | (m) | $105.37M | (m) | (m) | 3.93% | 1.79× |
| 2024-03-29 | $72.95M | (m) | $197.26M | $124.32M | (m) | $1.63B | (m) | $98.09M | (m) | (m) | 4.47% | 2.01× |
| 2023-12-31 | $60.27M | (m) | $180.21M | $119.94M | (m) | $1.60B | (m) | $90.65M | (m) | (m) | 3.78% | 1.99× |
| 2023-09-29 | $61.71M | (m) | $176.23M | $114.52M | (m) | $1.56B | (m) | $82.41M | (m) | (m) | 3.97% | 2.14× |
| 2023-06-30 | $32.17M | (m) | $141.70M | $109.53M | (m) | $1.49B | (m) | $71.21M | (m) | (m) | 2.15% | 1.99× |
| 2023-03-31 | $15.85M | (m) | $104.41M | $88.56M | (m) | $1.44B | (m) | $68.08M | (m) | (m) | 1.10% | 1.53× |
| 2022-12-31 | $41.65M | (m) | $116.38M | $74.73M | (m) | $1.38B | (m) | $66.38M | (m) | (m) | 3.03% | 1.75× |
| 2022-09-30 | $37.19M | (m) | $104.03M | $66.85M | (m) | $1.32B | (m) | $72.05M | (m) | (m) | 2.82% | 1.44× |
| 2022-07-01 | $67.23M | (m) | $124.89M | $57.66M | (m) | $1.28B | (m) | $78.06M | (m) | (m) | 5.25% | 1.60× |
| 2022-04-01 | $81.73M | (m) | $138.40M | $56.67M | (m) | $1.24B | (m) | $86.66M | (m) | (m) | 6.58% | 1.60× |
| 2021-12-31 | $103.20M | (m) | $156.67M | $53.46M | (m) | $1.22B | (m) | $96.81M | (m) | (m) | 8.45% | 1.62× |
| 2021-10-01 | $147.15M | (m) | $188.51M | $41.36M | (m) | $1.18B | (m) | $88.45M | (m) | (m) | 12.50% | 2.13× |
| 2021-07-02 | $133.61M | (m) | $172.17M | $38.57M | (m) | $1.11B | (m) | $96.72M | (m) | (m) | 12.06% | 1.78× |
| 2021-04-02 | $145.81M | (m) | $185.37M | $39.57M | (m) | (m) | (m) | $67.68M | (m) | (m) | (m) | 2.74× |
| 2020-12-31 | $134.51M | (m) | $181.34M | $46.83M | (m) | $1.07B | (m) | $77.26M | (m) | (m) | 12.53% | 2.35× |
| 2020-10-02 | $104.94M | (m) | $163.62M | $58.68M | (m) | $1.13B | (m) | $72.86M | (m) | (m) | 9.29% | 2.25× |
| 2020-07-03 | $116.39M | (m) | $175.76M | $59.37M | (m) | $1.20B | (m) | $73.10M | (m) | (m) | 9.72% | 2.40× |
| 2020-04-03 | $130.84M | (m) | $186.52M | $55.68M | (m) | $1.27B | (m) | $105.77M | (m) | (m) | 10.29% | 1.76× |
| 2019-12-31 | $117.16M | (m) | $165.36M | $48.20M | (m) | $1.26B | (m) | $96.34M | (m) | (m) | 9.31% | 1.72× |
| 2019-09-27 | $122.27M | (m) | $158.54M | $36.27M | (m) | $1.24B | (m) | $111.06M | (m) | (m) | 9.90% | 1.43× |
| 2019-06-28 | $126.44M | (m) | $167.63M | $41.19M | (m) | $1.24B | (m) | $194.55M | (m) | (m) | 10.22% | 0.86× |
| 2019-03-29 | $91.02M | (m) | $132.41M | $41.40M | (m) | $1.24B | (m) | $181.51M | (m) | (m) | 7.36% | 0.73× |
| 2018-12-28 | $122.39M | (m) | $167.30M | $44.91M | (m) | $1.22B | (m) | $167.96M | (m) | (m) | 10.07% | 1.00× |
| 2018-09-28 | $107.94M | (m) | $154.52M | $46.58M | (m) | $1.54B | (m) | $196.56M | (m) | (m) | 7.01% | 0.79× |
| 2018-06-29 | $95.32M | (m) | $139.41M | $44.09M | (m) | $1.52B | (m) | $96.17M | (m) | (m) | 6.27% | 1.45× |
| 2018-03-30 | $111.38M | (m) | $156.85M | $45.47M | (m) | $1.50B | (m) | $79.14M | (m) | (m) | 7.43% | 1.98× |
| 2017-12-29 | $102.06M | (m) | $149.36M | $47.30M | (m) | $1.46B | (m) | $66.68M | (m) | (m) | 6.98% | 2.24× |
| 2017-09-29 | $103.58M | (m) | $149.30M | $45.72M | (m) | $1.43B | (m) | $20.27M | (m) | (m) | 7.24% | 7.36× |
| 2017-06-30 | $98.28M | (m) | $148.94M | $50.67M | (m) | $1.41B | (m) | $18.04M | (m) | (m) | 6.95% | 8.26× |
| 2017-03-31 | $62.11M | (m) | $114.30M | $52.19M | (m) | $1.40B | (m) | $14.28M | (m) | (m) | 4.44% | 8.00× |
| 2016-12-30 | $46.90M | (m) | $105.53M | $58.63M | (m) | $1.39B | (m) | $5.96M | (m) | (m) | 3.38% | 17.70× |
| 2016-09-30 | $-6.98M | (m) | $53.29M | $60.28M | (m) | $1.34B | (m) | $-26.88M | (m) | (m) | -0.52% | -1.98× |
| 2016-07-01 | $-29.11M | (m) | $23.74M | $52.84M | (m) | $1.14B | (m) | $-38.31M | (m) | (m) | -2.54% | -0.62× |
| 2016-04-01 | $-13.00M | (m) | $35.01M | $48.00M | (m) | $971.33M | (m) | $-28.26M | (m) | (m) | -1.34% | -1.24× |
| 2016-01-01 | $-32.14M | (m) | $12.48M | $44.62M | (m) | $800.41M | (m) | $-7.59M | (m) | (m) | -4.02% | -1.64× |
| 2015-10-02 | $17.48M | (m) | $57.58M | $40.10M | (m) | $652.57M | (m) | $31.49M | (m) | (m) | 2.68% | 1.83× |
| 2015-07-03 | $42.23M | (m) | $77.25M | $35.02M | (m) | $677.63M | (m) | $45.48M | (m) | (m) | 6.23% | 1.70× |
| 2015-04-03 | $47.38M | (m) | $81.61M | $34.23M | (m) | $674.83M | (m) | $48.54M | (m) | (m) | 7.02% | 1.68× |
| 2015-01-02 | $56.45M | (m) | $81.28M | $24.82M | (m) | $687.79M | (m) | $55.46M | (m) | (m) | 8.21% | 1.47× |
| 2014-10-03 | $75.73M | (m) | $95.36M | $19.63M | (m) | $694.68M | (m) | $51.06M | (m) | (m) | 10.90% | 1.87× |
| 2014-07-04 | $72.93M | (m) | $91.90M | $18.97M | (m) | $690.71M | (m) | $48.12M | (m) | (m) | 10.56% | 1.91× |
| 2014-04-04 | $53.56M | (m) | $71.35M | $17.79M | (m) | $689.96M | (m) | $45.53M | (m) | (m) | 7.76% | 1.57× |
| 2014-01-03 | $38.20M | (m) | $56.76M | $18.56M | (m) | $663.95M | (m) | $36.27M | (m) | (m) | 5.75% | 1.56× |
| 2013-09-27 | $18.98M | (m) | $41.36M | $22.38M | (m) | $646.51M | (m) | $20.93M | (m) | (m) | 2.94% | 1.98× |
| 2013-06-28 | $4.21M | (m) | $32.66M | $28.45M | (m) | $640.12M | (m) | $2.30M | (m) | (m) | 0.66% | 14.21× |
| 2013-03-29 | $19.67M | (m) | $57.65M | $37.98M | (m) | $635.34M | (m) | $-3.60M | (m) | (m) | 3.10% | -16.00× |
| 2012-12-28 | $23.76M | (m) | $64.83M | $41.07M | (m) | $646.18M | (m) | $-4.80M | (m) | (m) | 3.68% | -13.51× |
| 2012-09-28 | $33.09M | (m) | $71.00M | $37.91M | (m) | $628.74M | (m) | $6.40M | (m) | (m) | 5.26% | 11.10× |
| 2012-06-29 | $40.50M | (m) | $75.65M | $35.15M | (m) | $599.12M | (m) | $20.95M | (m) | (m) | 6.76% | 3.61× |
| 2012-03-30 | $38.23M | (m) | $64.50M | $26.28M | (m) | $579.09M | (m) | $25.64M | (m) | (m) | 6.60% | 2.52× |
| 2011-12-30 | $67.43M | (m) | $89.92M | $22.49M | (m) | $568.82M | (m) | $33.12M | (m) | (m) | 11.85% | 2.71× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $60.74M | (m) | $76.89M | $16.14M | (m) | $533.42M | (m) | $33.14M | (m) | (m) | 11.39% | 2.32× |
| 2010-10-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-01 | $52.09M | (m) | $71.77M | $19.67M | (m) | $521.82M | (m) | $-9.00M | (m) | (m) | 9.98% | -7.97× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |